Back to results
TerminatedPhase 1

Study Evaluating PAZ-417 in Cerebrospinal Fluid in Subjects With Alzheimer's Disease

NCT00739037

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

California Clinical Trials

Glendale, California, United States

View on ClinicalTrials.gov
Study Evaluating PAZ-417 in Cerebrospinal Fluid in Subjects With Alzheimer's Disease — TrialFind